Santen to acquire ophthalmic company Novagali

Novagali Pharma S.A.

France / Small-Cap Biopharma (<$1 billion)

$134.2m on 09/30/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Santen Pharmaceutical Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed